-
A brain-specific approach to RNA therapeutics: developing a novel protein delivery strategy for the central nervous system
https://braincanada.ca/funded-grants/a-brain-specific-approach-to-rna-therapeutics-developing-a-novel-protein-delivery-strategy-for-the-central-nervous-systemChallenge: Delivery of therapeutic proteins to the brain has been a longstanding barrier to CNS drug development. Project Overview Challenge: Delivery of therapeutic proteins to the brain has been a longstanding barrier to CNS drug development. Protein replacement or supplementation strategies hold...
-
A Catalyst for Global Connections: Science without Barriers or Borders
https://braincanada.ca/about/news-updates/a-catalyst-for-global-connections-science-without-barriers-or-bordersTaufik Valiante, Ph. D. Brain Canada’s vision of science without barriers or borders is promoting global thought and connections. Innovation does not hold a passport or recognize frontiers. Science knows no nation. The understanding of the brain, in health and in illness, requires knowledge,...
-
A combined in-vivo ex-vivo approach to investigate imaging biomarkers in ALS diagnosis and aetiology
https://braincanada.ca/funded-grants/a-combined-in-vivo-ex-vivo-approach-to-investigate-imaging-biomarkers-in-als-diagnosis-and-aetiologyAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor function and ultimately death. Project Overview Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor...
-
A critical examination of family caregivers’ views on and experiences with medical assistance in dying
https://braincanada.ca/funded-grants/a-critical-examination-of-family-caregivers-views-on-and-experiences-with-medical-assistance-in-dyingIndividuals with an incurable condition marked by decline and intolerable suffering and where death is reasonably foreseeable, as with dementia, now have access to medical assistance in dying (MAID). Project Overview Individuals with an incurable condition marked by decline and intolerable...
-
A Drug Screening Assay to Reduce LINGO-1 Amounts in Neurons
https://braincanada.ca/funded-grants/a-drug-screening-assay-to-reduce-lingo-1-amounts-in-neuronsThe LINGO-1 protein is strongly associated with Alzheimer’s disease and is a novel drug target. Project Overview The LINGO-1 protein is strongly associated with Alzheimer’s disease and is a novel drug target. LINGO-1 is a transmembrane protein that negatively regulates neuronal survival and...
-
A Drug Screening Platform to Increase Protein Expression Levels for Treatment of Neurological Disorders
https://braincanada.ca/funded-grants/a-drug-screening-platform-to-increase-protein-expression-levels-for-treatment-of-neurological-disordersNeurological and psychiatric diseases and disorders affect more than half the population. Project Overview Neurological and psychiatric diseases and disorders affect more than half the population. These disorders of the nervous system can span a range of illnesses, including generalized anxiety...
-
A Human System to study Immune-Ependymal Cell Relationships
https://braincanada.ca/funded-grants/a-human-system-to-study-immune-ependymal-cell-relationshipsEpendymal cells are a largely understudied barrier cell type in the brain that provide a wall between brain tissue and brain fluid (cerebral spinal fluid, CSF), playing an important role in regulating fluid balance. Project Overview Ependymal cells are a largely understudied barrier cell type in...
-
A Legacy of Leadership
https://braincanada.ca/about/news-updates/a-legacy-of-leadershipWhen Naomi Azrieli, O.C., DPhil, first stepped into the role of Chair of Brain Canada, she brought with her not only deep philanthropic experience, but a profound belief in what bold scientific inquiry could make possible. Over the next eight years, that conviction helped fuel a period of...
-
A Lonely Path That Impacts Everyone
https://braincanada.ca/about/news-updates/a-lonely-path-that-impacts-everyoneNicole Hagley, an educator, past national athlete, and now yoga instructor, is still actively recovering from a bike accident two years ago. “We need people to understand the diversity of the brain, and the fact that no two brain injuries are the same.” “Even though you have an amazing circle of...
-
A machine-learning approach to personalized risk prediction for recurrent ischemic stroke using population-level event data and routine brain imaging
https://braincanada.ca/funded-grants/a-machine-learning-approach-to-personalized-risk-prediction-for-recurrent-ischemic-stroke-using-population-level-event-data-and-routine-brain-imagingIschemic stroke, caused by a blood clot in the brain, is a leading cause of death, disability, and dementia. Project Overview Ischemic stroke, caused by a blood clot in the brain, is a leading cause of death, disability, and dementia. One in four of these strokes happens in patients who already had...